What is the current GNOM expected move?

As of Jun 30, 2026, Global X - Genomics & Biotechnology ETF (GNOM) has an expected move of 9.20% over the next 17 days, implying a one-standard-deviation price range of $51.65 to $62.13 from the current $56.89. The expected move is derived from at-the-money straddle pricing and represents the market consensus for a ±1σ price move.

What does the GNOM expected move mean for traders?

Roughly 68% of outcomes should fall within ±1 expected move and 95% within ±2 under lognormal assumptions, though equity returns have empirically fatter tails than log-normal predicts. Strategies sized to the expected move (iron condors at ±1σ, strangles at ±1.5σ) target the typical outcome distribution; strategies that profit from tail moves (long-vol structures, ratio backspreads) target the tails the lognormal model under-prices.

How is GNOM expected move calculated?

The expected move displayed here is derived from at-the-money implied volatility scaled to the chosen tenor: expected move % is approximately ATM IV times sqrt(T / 365), where T is days to expiration. An equivalent straddle-based form: the ATM straddle (call + put at the same strike) is roughly sqrt(2/pi) times spot times IV times sqrt(T/365), so the implied one-standard-deviation move is approximately 1.25 times ATM straddle divided by spot. The two formulations agree once the sqrt(2/pi) constant is reconciled.

Global X - Genomics & Biotechnology ETF (GNOM) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Global X - Genomics & Biotechnology ETF (GNOM) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $76.2M, listed on NASDAQ, carrying a beta of 1.62 to the broader market. The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. public since 2019-04-10.

Snapshot as of Jun 30, 2026.

Spot Price: $56.89
Expected Move: 9.2%
Implied High: $62.13
Implied Low: $51.65
Front DTE: 17 days

As of Jun 30, 2026, Global X - Genomics & Biotechnology ETF (GNOM) has an expected move of 9.20%, a one-standard-deviation implied price range of roughly $51.65 to $62.13 from the current $56.89. Expected move is derived from at-the-money straddle pricing and represents the market's pricing of a ±1σ move. Roughly 68% of outcomes should fall within this range under lognormal assumptions, though empirical markets have fatter tails.

GNOM Strategy Sizing to the Expected Move

With Global X - Genomics & Biotechnology ETF pricing an expected move of 9.20% from $56.89, risk-defined strategies sized to the implied range structurally target the modal outcome distribution. Iron condors with wings at the ±1σ expected move boundaries collect premium against the ~68% probability that spot stays inside the range under lognormal assumptions; strangles set wider at ±1.5σ or ±2σ target the tails but pay smaller per-trade premium. Long-vol structures (long straddles, ratio backspreads) profit when realized move exceeds the implied move, the inverse trade: they bet against the lognormal assumption itself, capitalizing on the empirically fatter equity-return tails.

How to read the GNOM implied-range chart

The shaded range above shows the one-standard-deviation implied price band at each listed expiration, derived from ATM implied volatility scaled to days-to-expiration. The front-tenor expected move is 9.20%, anchoring an implied range of approximately $51.65 to $62.13. Under lognormal assumptions, roughly 68% of outcomes fall inside that band; 95% fall inside ±2σ; 99.7% inside ±3σ. The empirical equity-return distribution has fatter tails than lognormal, so true tail-outcome frequency is moderately higher than these closed-form numbers suggest.

GNOM expected move and event pricing

Expected move widens with √time: a 5% 30-day move corresponds to roughly a 2.5% 7.5-day move and a 10% 120-day move. GNOM term-structure is in contango (slope 0.042), so longer-dated tenors price in proportionally more vol than √time scaling alone would suggest - typically because long-dated cycles include uncertain macro states. With IV rank at 10.2%, the implied move is at the low end of the typical GNOM range - cheap optionality for buyers, thin premium for sellers.

Sizing GNOM structures to the expected move

Iron condors with wings at ±1σ collect the modal-outcome premium; ±1.5σ widens probability of inside-range to ~87% but cuts collected premium roughly in half. Strangles do the inverse trade - they pay against the same lognormal distribution, profiting when realized exceeds implied. Calendar spreads bet on the slope of the term structure rather than the level. GNOM put/call volume ratio currently at 0.00 indicates speculative call flow dominates - look for upside-skewed sentiment. The expected move is the inputs the chain is pricing, not a forecast - realized moves above or below are normal under any distribution.

Learn how expected move is reported and how to read the data →

Shaded band shows the ±1σ implied price range (~68% probability under lognormal assumptions) at each expiration; the center line marks current spot. Bands widen with longer DTE since volatility scales with √time.

Per-expiration expected move for GNOM derived from ATM implied volatility at each listed expiration. Implied high/low bounds are computed as $56.89 × (1 ± expected move %). One standard-deviation range under lognormal assumptions, roughly 68% of outcomes fall inside.

Expiration	DTE	ATM IV	Expected Move	Implied High	Implied Low
Jul 17, 2026	17	32.1%	6.9%	$60.83	$52.95
Aug 21, 2026	52	36.3%	13.7%	$64.68	$49.10
Nov 20, 2026	143	35.5%	22.2%	$69.53	$44.25
Feb 19, 2027	234	35.6%	28.5%	$73.11	$40.67

Frequently asked GNOM expected move questions

What is the current GNOM expected move?: As of Jun 30, 2026, Global X - Genomics & Biotechnology ETF (GNOM) has an expected move of 9.20% over the next 17 days, implying a one-standard-deviation price range of $51.65 to $62.13 from the current $56.89. The expected move is derived from at-the-money straddle pricing and represents the market consensus for a ±1σ price move.
What does the GNOM expected move mean for traders?: Roughly 68% of outcomes should fall within ±1 expected move and 95% within ±2 under lognormal assumptions, though equity returns have empirically fatter tails than log-normal predicts. Strategies sized to the expected move (iron condors at ±1σ, strangles at ±1.5σ) target the typical outcome distribution; strategies that profit from tail moves (long-vol structures, ratio backspreads) target the tails the lognormal model under-prices.
How is GNOM expected move calculated?: The expected move displayed here is derived from at-the-money implied volatility scaled to the chosen tenor: expected move % is approximately ATM IV times sqrt(T / 365), where T is days to expiration. An equivalent straddle-based form: the ATM straddle (call + put at the same strike) is roughly sqrt(2/pi) times spot times IV times sqrt(T/365), so the implied one-standard-deviation move is approximately 1.25 times ATM straddle divided by spot. The two formulations agree once the sqrt(2/pi) constant is reconciled.